Peter N. Lewis and Jeremy Hirota

Peter N. Lewis is professor emeritus of biochemistry at the University of Toronto, board chair of the Charles H. Best Foundation, and CEO and co-founder of Rosetta Therapeutics. Jeremy Hirota is an assistant professor in the department of medicine at McMaster University, Canada Research Chair Respiratory Mucosal Immunology and CEO and co-founder of Infinotype.